These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16964195)

  • 21. The year's new drugs.
    Graul AI; Prous JR
    Drug News Perspect; 2005; 18(1):21-36. PubMed ID: 15753973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing number of biotechnology products near marketing, PMA survey shows.
    Clin Pharm; 1990 Jun; 9(6):408. PubMed ID: 2364647
    [No Abstract]   [Full Text] [Related]  

  • 23. An industry imperiled by regulatory bottlenecks.
    Naughton G
    Nat Biotechnol; 2001 Aug; 19(8):709-10. PubMed ID: 11479550
    [No Abstract]   [Full Text] [Related]  

  • 24. Market watch: upcoming market catalysts in Q3 2012.
    Jeng R
    Nat Rev Drug Discov; 2012 Jun; 11(7):508. PubMed ID: 22743969
    [No Abstract]   [Full Text] [Related]  

  • 25. Masters of efficiency.
    Hoag H
    Nat Biotechnol; 2007 Jan; 25(1):139-40. PubMed ID: 17211408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution and future of biopharmaceuticals.
    Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
    [No Abstract]   [Full Text] [Related]  

  • 27. Western biotechs ponder follow-on possibilities.
    Waltz E
    Nat Biotechnol; 2008 Sep; 26(9):962-3. PubMed ID: 18779793
    [No Abstract]   [Full Text] [Related]  

  • 28. Big pharmas seek biotechs that deliver.
    Dove A
    Nat Biotechnol; 2001 May; 19(5):398. PubMed ID: 11328985
    [No Abstract]   [Full Text] [Related]  

  • 29. Reality check for device-drug convergence.
    Ratner M
    Nat Biotechnol; 2007 Feb; 25(2):157-9. PubMed ID: 17287739
    [No Abstract]   [Full Text] [Related]  

  • 30. 25 breakout companies--biotech: Sirtris Pharmaceuticals, Bacterin, XDX.
    Stipp D; Boyle M; Stires D
    Fortune; 2005 May; 151(10):169. PubMed ID: 15931765
    [No Abstract]   [Full Text] [Related]  

  • 31. Spin cycles. Healthcare marketing-communications efforts have taken on increasing strategic importance.
    Romano M
    Mod Healthc; 2005 Nov; 35(47):28-30. PubMed ID: 16334365
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA scrutinizes human stem cell therapies.
    Fox JL
    Nat Biotechnol; 2008 Jun; 26(6):598-9. PubMed ID: 18536668
    [No Abstract]   [Full Text] [Related]  

  • 33. New pharma-biotech company formation in India.
    Saberwal G
    Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
    [No Abstract]   [Full Text] [Related]  

  • 34. First inhalable insulin approved.
    Katsnelson A
    Nat Biotechnol; 2006 Apr; 24(4):369-70. PubMed ID: 16601705
    [No Abstract]   [Full Text] [Related]  

  • 35. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 36. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 38. CD20 blockers eye crowded rheumatology market.
    Mack GS
    Nat Biotechnol; 2008 Oct; 26(10):1053-4. PubMed ID: 18846053
    [No Abstract]   [Full Text] [Related]  

  • 39. Allergic rhinitis: market evolution.
    Clark MJ; Million RP
    Nat Rev Drug Discov; 2009 Apr; 8(4):271-2. PubMed ID: 19337269
    [No Abstract]   [Full Text] [Related]  

  • 40. Edison Liu.
    Liu E
    Nat Biotechnol; 2011 Mar; 29(3):189. PubMed ID: 21390008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.